VOOZH about

URL: https://pubmed.ncbi.nlm.nih.gov/32840560/

⇱ Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), a newly emerged pathogen: an overview - PubMed


Clipboard, Search History, and several other advanced features are temporarily unavailable.
Skip to main page content
👁 Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

👁 Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Abstract

Coronavirus disease 2019 (COVID-19) is a viral pneumonia, responsible for the recent pandemic, and originated from Wuhan, China, in December 2019. The causative agent of the outbreak was identified as coronavirus and designated as severe acute respiratory syndrome coronavirus 2 (SARS- CoV-2). Few years back, the severe acute respiratory syndrome coronavirus (SARS- CoV) and the Middle East respiratory syndrome coronavirus (MERS-CoV) were reported to be highly pathogenic and caused severe infections in humans. In the current situation SARS-CoV-2 has become the third highly pathogenic coronavirus that is responsible for the present outbreak in human population. At the time of this review, there were more than 14 007 791 confirmed COVID-19 patients which associated with over 597 105 deaths in more then 216 countries across the globe (as reported by World Health Organization). In this review we have discussed about SARS-CoV, MERS-CoV and SARC-CoV-2, their reservoirs, role of spike proteins and immunogenicity. We have also covered the diagnosis, therapeutics and vaccine status of SARS-CoV-2.

Keywords: COVID 19; MERS-CoV; SARS-CoV; SARS-CoV-2; spike protein and therapeutics.

PubMed Disclaimer

Figures

👁 Figure 1.
Figure 1.
Schematic representation of the genomic organization of SARS-CoV-2. The orf1ab and orf1a encodes pp1ab and pp1a nonstructural proteins, respectively. The structural proteins are encoded by the structural genes, including spike (S), envelope (E), membrane (M) and nucleocapsid (N) genes.
👁 Figure 2.
Figure 2.
Prospective interspecies transmission routes of MERS-CoV, SARS-CoV-2 and SARS-CoV.
👁 Figure 3.
Figure 3.
Schematic representation SARS-CoV-2 intercation with human receptor. The SARS-CoV-2 binds to a ACE2 through the receptor-binding domain (RBD) in the S1 domain of S protein, followed by fusion with cell membrane.
👁 Figure 4.
Figure 4.
Diagrammatic representation of functional domains of S protein in SAS-CoV-2. The SP, signal peptide; NTD, N-terminal domain; RBD, receptor-binding domain; FP, fusion peptide, HR1, heptad repeat 1; HR2, heptad repeat 2; TM, transmembrane domain; CP, cytoplasmic domain.
👁 Figure 5.
Figure 5.
Diagrammatic representation of SARS-CoV-2 targets, for the neutralizing antibodies, vaccines design and various entry/fusion inhibitors.

References

    1. Amanat Fatima KF. SARS-CoV-2 vaccines: status report. Cell. 2020;52:1–7. - PMC - PubMed
    1. Chan-Yeung M, Xu RH. SARS: epidemiology. Respirology (Carlton, Vic.). 2003;8:S9–14. - PMC - PubMed
    1. Chen N, Zhou M, Dong X et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395:507–13. - PMC - PubMed
    1. Chorin E, Dai M, Shulman E et al. The QT interval in patients with COVID-19 treated with hydroxychloroquine and azithromycin. Nat Med. 2020;26:808–9. - PubMed
    1. Clinical management of COVID-19 https://www.who.int/publications/i/item/clinical-management-of-covid-19.

MeSH terms

Cite

NCBI Literature Resources

MeSH PMC Bookshelf Disclaimer

The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Unauthorized use of these marks is strictly prohibited.